EU approves Gilead's Trodelvy combo with Keytruda for front-line TNBC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/6/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to EU approves Gilead's Trodelvy combo with Keytruda for front-line TNBC
Gilead Sciences (NASDAQ: GILD) Delayed: 151.00 -0.22 (0.15%)
Previous Close $151.22    52 Week High $108.63 
Open $149.23    52 Week Low $71.39 
Day High $151.19    P/E 83.43 
Day Low $149.23    EPS $1.81 
Volume 6,181,391